ETF Channel: Vanguard ESG U.S. Stock ETF Implied Analyst Target Price at $123.21

The Vanguard ESG U.S. Stock ETF (ESGV) has an implied analyst target price of $123.21 per unit, representing a 10.78% upside from its current price of $111.22. The ETF's underlying holdings with notable upside to their analyst target prices are Recursion Pharmaceuticals (RXRX), LegalZoom.com (LZ), and Papa John's International (PZZA). Analysts see 20.54% upside for RXRX, 17.89% for LZ, and 16.26% for PZZA.

The Vanguard ESG U.S. Stock ETF (ESGV) has recently garnered attention from analysts, with an implied target price of $123.21 per unit, representing a 10.78% upside from its current price of $111.22. The ETF's underlying holdings, which analysts believe have notable upside potential, include Recursion Pharmaceuticals (RXRX), LegalZoom.com (LZ), and Papa John's International (PZZA).

Recursion Pharmaceuticals (RXRX)
Analysts see a significant 20.54% upside for RXRX, driven by the company's strong financial position and strategic focus. Recursion Pharmaceuticals reported a 33% increase in Q2 2025 revenue, reaching $19.3 million, which was largely attributed to collaboration milestones. The company's substantial cash reserves of $533.3 million, projected to sustain operations until the fourth quarter of 2027, further support its financial health [3].

LegalZoom.com (LZ)
LegalZoom.com has also attracted analyst attention, with a 17.89% upside potential. The company reported quarterly earnings of $0.13 per share, matching analysts' expectations, with revenues reaching $183.11 million. Mackenzie Financial Corp, an institutional investor, increased its stake in LegalZoom.com by 104.9%, acquiring an additional 88,218 shares and owning approximately $1.48 million in the company as of the end of the first quarter [4].

Papa John's International (PZZA)
Papa John's International (PZZA) is another notable holding in ESGV with a 16.26% upside potential. The company's strong financial performance and strategic initiatives have contributed to its positive outlook. Analysts have highlighted the company's ability to adapt to market changes and maintain its competitive edge in the fast-food industry.

Conclusion
The Vanguard ESG U.S. Stock ETF (ESGV) offers a diversified portfolio with potential upside in its underlying holdings. Recursion Pharmaceuticals, LegalZoom.com, and Papa John's International are among the ETF's notable holdings with significant analyst target price increases. Investors should consider the potential risks and rewards associated with these holdings and consult with financial professionals for personalized advice.

References
[1] https://finance.yahoo.com/quote/ESGV/performance/
[2] https://www.tipranks.com/news/ratings/recursion-pharmaceuticals-strong-financial-position-and-strategic-focus-justify-buy-rating-ratings
[3] https://theoutpost.ai/news-story/recursion-pharmaceuticals-reports-33-revenue-jump-in-q2-2025-highlighting-ai-driven-drug-discovery-progress-18714/
[4] https://www.marketbeat.com/instant-alerts/filing-mackenzie-financial-corp-buys-88218-shares-of-legalzoomcom-inc-nasdaqlz-2025-08-05/